Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8236960 | International Journal of Radiation Oncology*Biology*Physics | 2009 | 9 Pages |
Abstract
The CR, local control, and survival rates are similar to previously observed results of RHT in the randomized Dutch Deep Hyperthermia Trial. Reported treatment results for currently applied combined treatment modalities (i.e., RT with chemotherapy and/or HT) do not permit definite conclusions about which combination is superior. The present results confirm previously shown beneficial effects from adding HT to RT and justify the application of RHT as first-line treatment in patients with LACC as an alternative to chemoradiation.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Martine M.D., Ludy C. M.D., Ph.D., Peter C. M.D., Ph.D., Catharina E. M.D., Elsbieta M. M.D., Jan J. M.D., Jan Willem M.D., Ph.D., Carien L. M.D., Ph.D., Michel F. M.D., Yvette M.Sc., Ph.D., Richard A.M. M.Sc., Gerard C. Ph.D., Jacoba M.D., Ph.D.,